Table 2 Comparison of Clinical Characteristics Between PCAG and NPCAG

Additional fasting and gastrointestinal decompression, n (%)

12(16.7)

4(7.4)

Analgesics use due to breakthrough pain, n (%)

2(2.8)

4(7.4)

Review time, median (IQR), d

5(4–5)

4(4–5)

Intestinal stasis and abnormal intestinal dilation, n (%) ^a

13(18.1)

3(5.6)

Intestinal wall thickening, n (%) ^a

4(5.6)

1(1.9)

Slowed intestinal peristalsis or anti-peristalsis, n (%) ^a

3(4.2)

0(0)

Peritoneal effusion, n (%) ^a

37(51.4)

35(64.8)

VAS at the end of surgery, n (%) ^b

0(0)

1(1.9)

VAS within 24 h after surgery, n (%) ^b

16(22.2)

18(33.3)

Use laxatives more than twice, n (%)

12(16.7)

2(3.7)

Analgesics use due to breakthrough pain, n (%)

2(2.8)

4(7.4)

Fasting time, median (IQR), h

72(60–84)

62(48–72)

Postoperative discharge time, median (IQR), d

7(6–7)

7(6–7)

Readmission due to intestinal obstruction, n (%)

5(6.9)

2(3.7)